Quick Order Cart

Cat. No. ARG38114

ARPC5 Knockout HEK293T Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Kidney

ARPC5 Knockout HEK293T Polyclonal Cells provide a CRISPR/Cas9-edited polyclonal population for loss-of-function analysis of the ARP2/3 complex subunit ARPC5. The knockout disrupts actin branching essential for lamellipodia formation and cell motility, offering a model to study signaling pathways involving Rac1, Cdc42, WASP, and WAVE. This product is ideal for investigating actin cytoskeleton dynamics, cell migration, and invasion in cancer and immunodeficiency research. Applications include scratch wound healing, transwell assays, and live-cell imaging of actin dynamics.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    HEK293T

    Sex of Donor

    Female

    Age

    Fetus

    Derived From Site

    Fetal kidney

    Gene Name

    ARPC5

    Gene Identifier

    NCBI Gene ID 10092

    Growth Mode

    Adherent

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    DMEM

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

ARPC5 Knockout HEK293T Polyclonal Cells represent a CRISPR/Cas9-edited polyclonal knockout cell population derived from the widely used HEK293T human embryonic kidney cell line. This loss-of-function model disrupts the ARPC5 gene, which encodes the p16 subunit of the actin-related protein 2/3 (ARP2/3) complex. Generated by CRISPR/Cas9-mediated gene disruption, the polyclonal population retains genetic heterogeneity, enabling robust functional studies without the bias of monoclonal selection. Researchers can employ these cells to interrogate the role of ARPC5 in actin cytoskeleton organization and related cellular processes.

The host cell line, HEK293T, is a human embryonic kidney epithelial cell line that constitutively expresses the SV40 large T antigen, which permits episomal replication of plasmids containing the SV40 origin of replication. This feature, combined with its high transfectability and rapid growth, makes HEK293T a preferred model for transient protein expression, lentiviral and retroviral packaging, and protein production. The epithelial origin and immortalized nature of HEK293T provide a controlled genetic background for investigating actin-dependent processes, including cell adhesion, spreading, and motility.

ARPC5 is an indispensable component of the seven-subunit ARP2/3 complex, which nucleates branched actin filament networks essential for force generation at the leading edge of migrating cells. The complex is activated downstream of Rho family GTPases, notably Rac1 and Cdc42, through the WASP and WAVE family of nucleation-promoting factors. ARPC5 directly interacts with ARP2, ARP3, and other ARPC subunits (ARPC1?C4) as well as regulatory proteins such as N-WASP, cortactin, and WAVE1?C3. Upon activation, the ARP2/3 complex binds to existing actin filaments and initiates daughter filament growth, forming dense, dendritic actin arrays that drive lamellipodial protrusion and cell migration. This pathway is tightly regulated by upstream signals including epidermal growth factor (EGF) and platelet-derived growth factor (PDGF).

In the HEK293T background, disruption of ARPC5 is expected to impair the formation of branched actin networks, leading to defects in lamellipodia extension, cell adhesion turnover, and directional migration. Given the cell line??s robust growth and genetic tractability, the knockout model enables detailed dissection of ARP2/3-dependent mechanisms without the complexity of primary cell cultures. This system is particularly valuable for investigating cancer-relevant processes, as ARP2/3-mediated actin assembly is frequently hijacked during tumor cell invasion and metastasis. Furthermore, the model can be utilized to study the role of actin dynamics in endocytic trafficking and vesicle movement within the cell.

These polyclonal knockout cells are suitable for a broad array of experimental approaches, including fluorescence microscopy with phalloidin to visualize F-actin distribution, scratch wound healing and transwell assays to quantify migration and invasion, and co-immunoprecipitation to probe ARP2/3 complex integrity. Live-cell imaging of actin reporters can reveal real-time alterations in cytoskeletal dynamics, while Rho GTPase activation assays help delineate upstream signaling defects. Researchers in cancer biology, immunology, and drug discovery can leverage this model to screen compounds targeting actin-regulatory pathways or to validate the role of ARPC5 in pathological states such as Wiskott-Aldrich syndrome and metastatic disease. For additional details or technical inquiries, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)